Deep Apple Therapeutics
Biotechnology company accelerating drug discovery using structure-based, ultra-large library virtual screening and deep learning models for computational drug design.
Notes
Deep Apple Therapeutics is a biotechnology company focused on accelerating drug discovery through computational approaches. The company leverages structure-based virtual screening of ultra-large chemical libraries combined with deep learning models to identify promising drug candidates more efficiently than traditional methods.
The company's approach addresses one of the key bottlenecks in pharmaceutical development: the time and cost required to screen vast chemical spaces for potential drug candidates. By using AI and computational methods, Deep Apple Therapeutics aims to dramatically reduce the time from target identification to lead compound discovery.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Focus on AI-driven drug discovery
- Uses structure-based virtual screening
- Applies deep learning to drug design
- Targets ultra-large chemical libraries
- Part of the growing AI drug discovery ecosystem
Sources
- Company website and public information pending
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |